Pathways to the diagnosis of ovarian cancer in the UK: A cohort study in primary care

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 5, 2010, Pages 610-614

  Barrett, J ^a   Sharp, D J ^b   Stapley, S ^a   Stabb, C ^a   Hamilton, W ^a,b  

^a CAPER Research Unit   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Diagnosis; Ovarian cancer; Pathways; Primary health care; Referral

Indexed keywords

ABDOMINAL MASS; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; COHORT ANALYSIS; ECHOGRAPHY; EMERGENCY; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED KINGDOM;

AGED; CA-125 ANTIGEN; CRITICAL PATHWAYS; FAMILY PRACTICE; FEMALE; HOSPITALIZATION; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; REFERRAL AND CONSULTATION; TIME FACTORS;

EID: 77949293813     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02499.x     Document Type: Article

References (23)

1. Cancer Research UK. CancerStats 2007. London : Cancer Research UK, 2007.
2. Bray F, Loos AH, Tognazzo S, Vecchia CL. Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer 2005 113 : 977 990.
3. Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JW, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007 8 : 773 783.
4. Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, Sessa C, et al. Ovarian cancer. Crit Rev Oncol Hematol 2006 60 : 159 179.
5. Quaye L, Gayther SA, Ramus SJ, Di Cioccio RA, McGuire V, Hogdall E, et al. The effects of common genetic variants in oncogenes on ovarian cancer survival. Clin Cancer Res 2008 14 : 5833 5839.
6. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007 8 : 784 796.
7. Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 2009 101 : S125 9.
8. Rufford BD, Jacobs IJ, Menon U. Feasibility of screening for ovarian cancer using symptoms as selection criteria. BJOG 2007 114 : 59 64.
9. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009 10 : 327 340.
10. Goff BA, Mandel L, Muntz HG, Melancon CH. Ovarian carcinoma diagnosis. Cancer 2000 89 : 2068 2075.
11. Goff B, Mandel L, Melancon C, Muntz H. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 2004 291 : 2705 2712.
12. Vine MF, Calingaert B, Berchuck A, Schildkraut JM. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol 2003 90 : 75 82.
13. Hamilton W, Peters TJ, Bankhead C, Sharp D. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ 2009 339 (aug25-2 b2998.
14. Tate A, Martin A, Murray-Thomas T, Anderson S, Cassell J. Determining the date of diagnosis - is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care. BMC Med Res Methodol 2009 9 : 42.
15. Bankhead C, Kehoe S, Austoker J. Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG 2005 112 : 857 865.
16. Zorn KK, Tian C, McGuire WP, Hoskins WJ, Markman M, Muggia FM, et al. The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study. Cancer 2009 115 : 1028 1035.
17. Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu J-L, Church TR, et al. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol 2009 113 : 775 782.
18. Sturgeon CM, Lai LC, Duffy MJ. Serum tumour markers: how to order and interpret them. BMJ 2009 339 (sep22-1 b3527.
19. NICE. Referral Guidelines for Suspected Cancer. London : NICE, 2005.
20. Allgar V, Neal R. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer. Br J Cancer 2005 92 : 1959 1970.
21. Barrett J, Hamilton W. Pathways to the diagnosis of lung cancer in the UK: a cohort study. doi :. BMC Fam Pract 2008 9 : 31.
22. Barrett J, Jiwa M, Rose P, Hamilton W. Pathways to the diagnosis of colorectal cancer: an observational study in three UK cities. Fam Pract 2006 23 : 15 9.
23. Target Ovarian Cancer. Pathfinder Study. London : Target Ovarian Cancer, 2009 : 32.